Eularis

The pharma sector continues to evolve with revolutionary innovations, overhauling of the regulatory process, and changing patterns of demand.  Assessing emerging Pharma growth  and competitiveness are based on evaluating future trends. At Eularis , we know how crucial it is to have strategic insight in the face of industry intricacies and are determined to assist firms in identifying and leveraging such future trends. In this blog, we’ll explore key trends shaping the pharma landscape and discuss strategies for future growth. 1. Digital Transformation and AI Integration Digitalization has emerged as one of the major trends in the pharma sector over the last few years. Technology deployment in the guise of artificial intelligence (AI) and machine learning (ML) is transforming the entire value chain from drug discovery to patient interaction. AI-powered analytics can accelerate R&D with predictive outcomes, drug candidate identification, and optimization of clinical trials. ...

AI has transformative potential for any organization that wishes to work smarter, make more informed decisions, and begin to understand unconventional approaches to doing its work. However, taking an AI strategy to implementation presents many hurdles, such as data integration issues, model scalability, and regulatory compliance. Eularis' AI Deployment Blueprint provides clarity on the path to smoothly integrating AI calculation-wise for realizing positive business consequences. ​ Understanding AI Deployment Challenges Various entities put money into Artificial Intelligence without a strategy. Even when a specific strategy is lacking, some notable pitfalls include: • Unclear Objectives: Lack of alignment between AI initiative activities and business objectives. • Data Siloes: Inaccessible or bad-quality data hampers AI performance. • Integration Issues: Difficulties in attaching AI to operational systems. • Scalability Issues: Models work in small pilot phases but fail to deliver ...